SCHEMBL13617477

SCHEMBL13617477

BC[C@@H](c1ccc(OCCCC)c2[nH]c(=O)ccc12)C(C)C(C)(C)[Si](C)(C)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 15/20 0.37
DRD2 P14416 3/20 0.32
KDM4E B2RXH2 3/20 0.32
ADRB1 P08588 3/20 0.32
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
PTGS2 P35354 1/20 0.32
KMT2A Q03164 1/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
DRD1 P21728 2/20 0.32
DRD4 P21917 2/20 0.32
DRD3 P35462 2/20 0.32
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13617663 0.79 ADRB2 (0.44) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL13824492 0.76 ADRB2 (0.36) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL14417497 0.75 ADRB2 (0.35) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL13617868 0.74 ADRB2 (0.47) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL15630202 0.73 ADRB2 (0.43) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL18601883 0.72 ADRB2 (0.42) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL13697685 0.72 ADRB2 (0.42) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL16066905 0.72 ADRB2 (0.42) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL18601882 0.69 ADRB2 (0.36) ADRB2DRD2KDM4EADRB1LMNA
SCHEMBL15630094 0.69 ADRB2 (0.36) ADRB2DRD2KDM4EADRB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1641465-B1 COMBINATIONS OF AN ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONIST AND A CORTICOSTEROID THERAVANCE INC (US) 2009-11-04 EP disclosed